| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
March 15, 2018 |
|
|
| |
|
|
| |
|
|
|
CfPA-The Center for Professional Advancement, New Brunswick, NJ
October 3-4, 2018
Who Should Attend?
This course is designed for those who already have some experience in managing GLP studies; those who wish to extend their role to study direction and their competence in study management, particularly in the complex multi-site environment. The course will benefit the following individuals:
• Existing Study Directors who wish to upgrade their competence
in a multi-site situation
• The newly appointed Study Director
• Study Supervisors who wish to become Study Directors
• Study Monitors
• Principal Investigators in the field of Preclinical Regulatory R&D
• Coordinators of multi-site projects Course Description
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA-The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
 David Long; Long and Associates International Consulting Ltd. |
David Long worked for Rhône Poulenc Health Division (now Sanofi-Aventis) in Quality Assurance (QA) for over twenty years where he gained considerable experience in all three Good Practice disciplines, GLP, GCP and GMP. When he left Rhône-Poulenc he was Senior Director R&D worldwide for Quality and for Process Improvement. Mr. Long has since worked for CHIMEX, a manufacturing subsidiary of the L’Oreal group and now runs his own consultancy company.
David Long has always shown a keen interest in promoting professional QA activities. He was a founding member and President of the French QA Society and a founding member and President of the European QA Federation. He was also the founder and Chief Editor of the Quality Assurance Journal, an international scientific journal specifically addressing subjects of interest to R&D and QA personnel.
He has lectured and trained widely and has been an active participant in developing training in Good Practices and QA, working with a number of international groups including the OECD and the WHO. His latest contribution through the WHO has been in the co-authoring of a set of guidelines for research performed upstream of the regulatory scene, called “Quality Practices in Basic Biomedical Research”.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
jmorbit@cfpa.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|
Dealing with the increased range of duties and responsibilities of study managers is the core issue of this course.
The course goes further than presenting the theoretical roles of study managers in the difficult arena of multi-site studies. The workshop based activities address the practical aspects of study direction and investigate possible solutions to ensure full compliance.
A strong feature of this course is the high level of interactive, dynamic problem solving situations that the participants are asked to resolve appropriately and speedily. The strategies available for managing compliant studies are given topmost priority.
The presenter recognizes that many courses can provide information, but information can only be turned into knowledge through the depth of understanding that comes from sharing experience and exchanging ideas. This is why a workshop approach is so valuable.
Maximize Your Learning!
Attend this course and its Companion Courses:
Good Laboratory Practices (GLP)
September 26-28, 2018 • New Brunswick, NJ • Course ID #545
GLP and Quality Assurance: Developing a GLP Compliant QA Program
October 1-2, 2018 • New Brunswick, NJ • Course ID #2564